TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial

Authors: Élisabeth Quoix, H. Léna, György Losonczy, Frédéric Forget, C. Chouaïd, Zsolt Pápai, Radj Gervais, Christian H. Ottensmeier, Aleksandra Szczęsna, Andrzej Każarnowicz, J. Thaddeus Beck, Virginie Westeel, Enriqueta Felip, D. Debieuvre, Anne Madroszyk, Julien Adam, G Lacoste, Annette Tavernaro, Bérangère Bastien, Céline Halluard, Tania Palanché, Jean‐Marc Limacher - The Lancet 2015 cited by 207